These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33541012)

  • 1. Does antiretroviral therapy cause congenital malformations? A systematic review and meta-analysis.
    Alemu FM; Yalew AW
    Epidemiol Health; 2021; 43():e2021008. PubMed ID: 33541012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis.
    Tricco AC; Antony J; Angeliki VA; Ashoor H; Hutton B; Hemmelgarn BR; Moher D; Finkelstein Y; Gough K; Straus SE
    Syst Rev; 2014 May; 3():51. PubMed ID: 24887455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
    Veroniki AA; Antony J; Straus SE; Ashoor HM; Finkelstein Y; Khan PA; Ghassemi M; Blondal E; Ivory JD; Hutton B; Gough K; Hemmelgarn BR; Lillie E; Vafaei A; Tricco AC
    PLoS One; 2018; 13(6):e0198447. PubMed ID: 29912896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    Ford N; Mofenson L; Shubber Z; Calmy A; Andrieux-Meyer I; Vitoria M; Shaffer N; Renaud F
    AIDS; 2014 Mar; 28 Suppl 2():S123-31. PubMed ID: 24849471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis.
    Smith C; Fought AJ; Sung JF; McKinney JR; Metz TD; Fetters KB; Lazarus S; Capraro S; Barr E; Glenny C; Buehler J; Weinberg A;
    PLoS One; 2023; 18(6):e0276473. PubMed ID: 37307279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of interventions to improve uptake and retention of HIV-infected pregnant and breastfeeding women and their infants in prevention of mother-to-child transmission care programs in low- and middle-income countries: protocol for a systematic review and meta-analysis.
    Puchalski Ritchie LM; van Lettow M; Hosseinipour MC; Rosenberg NE; Phiri S; Landes M; Cataldo F; Straus SE;
    Syst Rev; 2015 Nov; 4():144. PubMed ID: 26525141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.
    Knapp KM; Brogly SB; Muenz DG; Spiegel HM; Conway DH; Scott GB; Talbot JT; Shapiro DE; Read JS
    Pediatr Infect Dis J; 2012 Feb; 31(2):164-70. PubMed ID: 21983213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N; Poolsup N; Ket-Aim S
    J Clin Pharm Ther; 2007 Jun; 32(3):293-311. PubMed ID: 17489882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis.
    Mesfin YM; Kibret KT; Taye A
    Reprod Health; 2016 Apr; 13():30. PubMed ID: 27048501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
    João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
    Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
    Bera E; McCausland K; Nonkwelo R; Mgudlwa B; Chacko S; Majeke B
    AIDS; 2010 Jan; 24(2):283-9. PubMed ID: 19864931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana.
    Ajibola G; Zash R; Shapiro RL; Batlang O; Botebele K; Bennett K; Chilisa F; Widenfelt EV; Makhema J; Lockman S; Holmes LB; Powis KM
    PLoS One; 2017; 12(3):e0173800. PubMed ID: 28339500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine use in pregnancy and congenital malformations.
    Rough K; Sun JW; Seage GR; Williams PL; Huybrechts KF; Bateman BT; Hernandez-Diaz S
    AIDS; 2017 Jul; 31(12):1733-1743. PubMed ID: 28537936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.